Jason Kurzer

Professional Education

Board Certification: Anatomic Pathology, American Board of Pathology (2011)

Residency: Stanford Hospital and Clinics (2011) CA

Fellowship: Stanford Hospital and Clinics (2010) CA

Board Certification: Hematopathology, American Board of Pathology (2011)

Medical Education: University of Michigan (2007) MI

Board Certification, American Board of Pathology, Anatomic Pathology (2011)

Board Certification, American Board of Pathology, Hematology (2011)

SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other
Maures, T. J., Kurzer, J. H., & Carter-Su, C. (2007). SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 18(1), 38-45.

Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state
Kurzer, J. H., Saharinen, P., Silvennoinen, O., & Carter-Su, C. (2006). Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. MOLECULAR AND CELLULAR BIOLOGY, 26(17), 6381-6394.

Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-B beta as a model system
Yang, P. L., Whelan, R. J., Jameson, E. E., Kurzer, J. H., Argetsinger, L. S., & Kennedy, R. T. (2005). Capillary electrophoresis and fluorescence anisotropy for quantitative analysis of peptide-protein interactions using JAK2 and SH2-B beta as a model system. ANALYTICAL CHEMISTRY, 77(8), 2482-2489.

Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta
Kurzer, J. H., Argetsinger, L. S., Zhou, Y. J., Kouadio, J. L., O'Shea, J. J., & Carter-Su, C. (2004). Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. MOLECULAR AND CELLULAR BIOLOGY, 24(10), 4557-4570.